Private Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Private Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$233K	Sell	3,005 -4,664	-61%	-$355K	0.18%	111
2022 Q1	$564K	Buy	7,669 +375	+5%	+$25.2K	0.13%	100
2021 Q4	$455K	Sell	7,294 -1,218	-14%	-$71.4K	0.1%	133
2021 Q3	$508K	Buy	8,512 +120	+1%	+$7.9K	0.11%	116
2021 Q2	$561K	Buy	8,392 +683	+9%	+$44.5K	0.13%	107
2021 Q1	$490K	Sell	7,709 -2,657	-26%	-$165K	0.12%	110
2020 Q4	$648K	Sell	10,366 -526	-5%	-$32.3K	0.12%	130
2020 Q3	$657K	Buy	10,892 +990	+10%	+$59.6K	0.14%	117
2020 Q2	$582K	Buy	9,902 +227	+2%	+$13.6K	0.13%	124
2020 Q1	$539K	Buy	9,675 +71	+0.7%	+$4.34K	0.14%	113
2019 Q4	$616K	Sell	9,604 -3,605	-27%	-$206K	0.13%	108
2019 Q3	$670K	Buy	13,209 +2,856	+28%	+$134K	0.12%	114
2019 Q2	$573K	Sell	10,353 -3,596	-26%	-$168K	0.13%	112
2019 Q1	$666K	Buy	13,949 +109	+0.8%	+$5.43K	0.13%	110
2018 Q4	$719K	Buy	13,840 +1,408	+11%	+$75.7K	0.16%	102
2018 Q3	$771K	Buy	12,432 +1,495	+14%	+$88.7K	0.15%	105
2018 Q2	$605K	Sell	10,937 -115	-1%	-$6.21K	0.13%	115
2018 Q1	$699K	Buy	11,052 +228	+2%	+$14.7K	0.16%	103
2017 Q4	$663	Buy	+10,824	New	+$677K	0.16%	101

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Private Capital Group's BMY Position: Q2 2022 in Review

Private Capital Group reduced its Bristol-Myers Squibb (BMY) stake by 61% in Q2 2022, selling an estimated $355K and leaving 3,005 shares worth $233K. The position accounts for 0.18% of the portfolio, ranked #111.

Private Capital Group first reported a position in BMY in Q4 2017 and has held it in 19 quarters since. The position peaked at $771K in Q3 2018. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Private Capital Group held 3,005 shares of Bristol-Myers Squibb worth $233K as of Q2 2022.
Private Capital Group sold 4,664 Bristol-Myers Squibb shares in Q2 2022, an estimated $355K.
Bristol-Myers Squibb made up 0.18% of Private Capital Group's portfolio in Q2 2022, its #111 holding.
Private Capital Group first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Bristol-Myers Squibb position peaked at $771K in Q3 2018.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.